After Theresa May announced a 10-year plan that included a £20bn a year increase in funding for the NHS by 2022, analysts at Berenberg believe that the medium-term potential acceleration in NHS volume growth for Spire Healthcare "outweighs longer-term potential lower self-pay growth".
Private healthcare provider Spire remained confident in hitting full-year targets even though market conditions remained challenging throughout the start of its trading year, which will lead to lower first-half revenues and earnings.
Provident financial: Berenberg downgrades to sell with a target price of 550p.
Sabre Insurance Group plc: Numis downgrades to add with a target price of 330.
Simon Rowlands, non-executive director of private healthcare provider Spire Healthcare, purchased 114,000 ordinary shares in the company on Wednesday, upping his stake to a total of 328,516 as a result.
Just Eat: Deutsche Bank downgrades to sell with a target price of 630p.
Justin Ash, chief executive of independent hospital group Spire Healthcare, picked up 46,500 ordinary shares in the London-based firm at a cost of 215.2p each on Wednesday.
Standard Life Aberdeen: Deutsche Bank upgrades to buy with a target price of 440p.
Big Yellow Group: Berenberg upgrades to buy with a target price of 920p.
FTSE 250 hospital group Spire Healthcare confirmed its previous guidance for 2017 on Tuesday.
Spire Healthcare Group: Berenberg upgrades to Buy with a target price of 310p.
Spire Healthcare got a shot in the arm on Wednesday as Berenberg upgraded its stance on the stock to 'buy' from 'hold' and lifted the price target to 310p from 270p on the back of new NHS data
Mediclinic updated the market on its ongoing efforts to acquire Spire Healthcare on Thursday, confirming it would consider share price movements in recent weeks before possibly making an amended offer.
Spire Healthcare's incoming new chief Justin Ash bought into the stock of the company he will soon be running just off its 52-week lows.
Countrywide: Credit Suisse downgrades to Underperform with a target price of 111p.
John Laing: HSBC initiates at Buy with a target price of 340p.
Petrofac: RBC upgrades to Sector Perform with a target price of 500p.
Spire Healthcare reported a 75% fall in first-half profits after a malpractice payment and warned the second half sales and profits would be lower than expected after a decline in NHS activity over the summer.
Spire Healthcare said on Wednesday that it will contribute £27.2m towards a compensation fund for victims of disgraced breast surgeon Iain Paterson, who left hundreds of patients scarred and disfigured after carrying out unnecessary operations.
Steel-maker Evraz rolled to the top of the leaderboard on the second-tier index in another risk-on day for metals generally speaking and for Chinese rebar futures in particular.